Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 12:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to introduce Giovanni Caforio, Chairman and CEO of Bristol-Myers to once again kick off the 39th annual and hopefully only virtual JPMorgan conference.

Before I turn it over to Giovanni, I just want to remind everybody, this is a 40-minute session. And if anybody has a question for the Q&A portion of today's meeting, (Operator Instructions).

With that, I'll turn the floor over to Giovanni.

Giovanni Caforio - Bristol-Myers Squibb Company - Chairman of the Board & CEO

Thank you, Chris, and good morning. Good morning, everyone. It's great to be here at JPMorgan again this year, although virtually.

And on Slide 2, you can see our forward-looking statements.

Let me start on Slide 3 by briefly reminding you about our strategy, which is to combine the innovation and agility of biotech with the strength and resources of a pharmaceutical company. As you know, this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot